APA

de la Fuente L. M., Stertzer S. H., Argentieri J., Peñaloza E., Koziner B., Rouy D. & Altman P. A. (20120314). Transendocardial autologous bone marrow in myocardial infarction induced heart failure, two-year follow-up in an open-label phase I safety study (the TABMMI study). : EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Chicago

de la Fuente Luis M, Stertzer Simon H, Argentieri Julio, Peñaloza Eduardo, Koziner Benjamin, Rouy Didier and Altman Peter A. 20120314. Transendocardial autologous bone marrow in myocardial infarction induced heart failure, two-year follow-up in an open-label phase I safety study (the TABMMI study). : EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Harvard

de la Fuente L. M., Stertzer S. H., Argentieri J., Peñaloza E., Koziner B., Rouy D. and Altman P. A. (20120314). Transendocardial autologous bone marrow in myocardial infarction induced heart failure, two-year follow-up in an open-label phase I safety study (the TABMMI study). : EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

MLA

de la Fuente Luis M, Stertzer Simon H, Argentieri Julio, Peñaloza Eduardo, Koziner Benjamin, Rouy Didier and Altman Peter A. Transendocardial autologous bone marrow in myocardial infarction induced heart failure, two-year follow-up in an open-label phase I safety study (the TABMMI study). : EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 20120314.